MileCell Biotechnology is pleased to announce its participation in the BIO International Convention 2026, taking place June 22–25 in San Diego, California.
As one of the world’s premier biotechnology partnering events, BIO International Convention brings together biotechnology innovators, pharmaceutical companies, investors, service providers, and research organizations from around the globe. The event provides a unique opportunity to explore new collaborations, discuss emerging technologies, and build strategic relationships that support the future of life science innovation.
MileCell’s Chief Commercial Officer, Wayne Vaz, will represent the company throughout the conference and participate in BIO One-on-One Partnering™ meetings with organizations interested in advancing next-generation research platforms, translational biology, and cell-based innovation.
Supporting the Next Generation of Human-Relevant Research Models
As organoids, microphysiological systems (MPS), organ-on-chip technologies, and other advanced in vitro models continue to gain momentum across drug discovery and preclinical development, collaboration across the life science ecosystem is becoming increasingly important.
At BIO 2026, MileCell is particularly interested in connecting with:
· Organoid and organ-on-chip (MPS) developers
· Translational biology and advanced in vitro model companies
· CROs and CDMOs seeking cell sourcing and workflow support
· Distribution and channel partners expanding their life science portfolios
· Biotechnology companies exploring long-term strategic collaborations
Many of today’s most promising research platforms are being built through partnerships that combine innovative technologies with reliable biological materials, scientific expertise, and scalable research workflows.
Cell Sourcing and Biological Infrastructure for Emerging Platforms
MileCell supports researchers and technology developers through high-quality biological materials and cell sourcing solutions that help enable reproducible and scalable research workflows.
Our portfolio supports a broad range of applications including:
· Drug discovery and preclinical development
· ADME/DMPK and toxicology research
· Immunology and oncology studies
· Cell and gene therapy development
· Advanced in vitro model systems
As the industry continues to adopt more predictive and biologically relevant research approaches, access to reliable biological systems remains a critical component of successful platform development and translational research.
Meet with MileCell at BIO 2026
Organizations interested in discussing strategic collaboration opportunities are invited to connect with Wayne Vaz through BIO One-on-One Partnering™.
Discussion topics include:
· Cell sourcing partnerships
· Organoid and MPS platform support
· CRO/CDMO collaboration opportunities
· Distribution and channel partnerships
· Strategic alliance discussions
We look forward to meeting with innovators, researchers, and industry leaders in San Diego and exploring new opportunities to advance the future of life science research together.
To schedule a meeting, connect with Wayne Vaz via BIO One-on-One Partnering™ during BIO 2026.
